New pharmaceuticals plant for Dammam Pharma

Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) said its 65%-owned subsidiary Dammam Pharma signed a contract on Sept. 29 to build a pharmaceuticals plant in Dammam First Industrial City with Absal Paul, a Saudi-Irish company, at a total value of SAR 134 million.

The project is likely to be completed at the end of the second quarter of 2016 – a delay of 12 months from what was previously declared.